These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

47 related articles for article (PubMed ID: 2566190)

  • 1.
    Sandoval KE; Witt KA
    Pharmacol Rev; 2024 Jul; ():. PubMed ID: 39013601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Corticotropin releasing factor-binding protein (CRF-BP) as a potential new therapeutic target in Alzheimer's disease and stress disorders.
    Vandael D; Gounko NV
    Transl Psychiatry; 2019 Oct; 9(1):272. PubMed ID: 31641098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The CRF System as a Therapeutic Target for Neuropsychiatric Disorders.
    Sanders J; Nemeroff C
    Trends Pharmacol Sci; 2016 Dec; 37(12):1045-1054. PubMed ID: 27717506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Corticotropin-releasing factor receptor-1 antagonism mitigates beta amyloid pathology and cognitive and synaptic deficits in a mouse model of Alzheimer's disease.
    Zhang C; Kuo CC; Moghadam SH; Monte L; Campbell SN; Rice KC; Sawchenko PE; Masliah E; Rissman RA
    Alzheimers Dement; 2016 May; 12(5):527-37. PubMed ID: 26555315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic and Non-Cognitive Manifestations of Alzheimer's Disease: The Hypothalamus as Both Culprit and Target of Pathology.
    Ishii M; Iadecola C
    Cell Metab; 2015 Nov; 22(5):761-76. PubMed ID: 26365177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of CRFR1 Ablation on Amyloid-β Production and Accumulation in a Mouse Model of Alzheimer's Disease.
    Campbell SN; Zhang C; Roe AD; Lee N; Lao KU; Monte L; Donohue MC; Rissman RA
    J Alzheimers Dis; 2015; 45(4):1175-84. PubMed ID: 25697705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dissecting the role of sortilin receptor signaling in neurodegeneration induced by NGF deprivation.
    Capsoni S; Amato G; Vignone D; Criscuolo C; Nykjaer A; Cattaneo A
    Biochem Biophys Res Commun; 2013 Feb; 431(3):579-85. PubMed ID: 23313508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Longitudinal brain corticotropin releasing factor and somatostatin in a transgenic mouse (TG2576) model of Alzheimer's disease.
    Horgan J; Miguel-Hidalgo JJ; Thrasher M; Bissette G
    J Alzheimers Dis; 2007 Sep; 12(2):115-27. PubMed ID: 17917156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Somatostatin-like immunoreactivity, its molecular forms and monoaminergic metabolites in aged and demented patients with Parkinson's disease--effect of L-Dopa.
    Strittmatter M; Hamann GF; Strubel D; Cramer H; Schimrigk K
    J Neural Transm (Vienna); 1996; 103(5):591-602. PubMed ID: 8811504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuropeptide gene expression in brain is differentially regulated by midbrain dopamine neurons.
    Lindefors N; Brené S; Herrera-Marschitz M; Persson H
    Exp Brain Res; 1990; 80(3):489-500. PubMed ID: 2387350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NADPH-diaphorase-positive cell populations in the human amygdala and temporal cortex: neuroanatomy, peptidergic characteristics and aspects of aging and Alzheimer's disease.
    Unger JW; Lange W
    Acta Neuropathol; 1992; 83(6):636-46. PubMed ID: 1378987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Corticotropin-releasing factor-like immunoreactivity in senile dementia of the Alzheimer type. Reduced cortical and striatal concentrations.
    Bissette G; Reynolds GP; Kilts CD; Widerlöv E; Nemeroff CB
    JAMA; 1985 Dec; 254(21):3067-9. PubMed ID: 3877182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of sertraline on regional neuropeptide concentrations in olfactory bulbectomized rats.
    Bissette G
    Pharmacol Biochem Behav; 2001; 69(1-2):269-81. PubMed ID: 11420095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peptides in the neocortex in Alzheimer's disease and ageing.
    Ferrier IN; Leake A
    Psychoneuroendocrinology; 1990; 15(2):89-95. PubMed ID: 1972799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Neuropeptides in Alzheimer's disease].
    Jiménez-Corral C; Morán-Sánchez JC; Alonso-Navarro H
    Rev Neurol; 2006 Mar 16-31; 42(6):354-9. PubMed ID: 16575772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuropeptides in Alzheimer's disease: a postmortem study.
    Nemeroff CB; Kizer JS; Reynolds GP; Bissette G
    Regul Pept; 1989 Apr; 25(1):123-30. PubMed ID: 2566190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent advances in the neurochemical pathology of Alzheimer's disease. Studies of neuropeptides, cholinergic function and Alzheimer's disease-associated protein.
    Nemeroff CB; Bissette G; Slotkin TA; Seidler FJ; Miller BE; Ghanbari H
    Ann N Y Acad Sci; 1991; 640():193-6. PubMed ID: 1685644
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.